About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,534 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,534 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 281-300 of 7,534 trials

UnknownMitoxantrone and G-CSF in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003183·Kansas City, Kansas and 1 other TerminatedA Study of the Drugs Talazoparib and Temozolomide in Prostate CancerThe purpose of this study is to determine what the safest dose of talazoparib plus temozolomide for participants with metastatic castration resistant prostate cancer.NCT04019327·Basking Ridge, New Jersey and 8 others CompletedRadiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for prostate cancer.NCT00002602·Birmingham, Alabama and 227 others

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedNon-systemic Treatment for Patients With Low-volume Metastatic Prostate CancerProstate cancer patients diagnosed with a biochemical recurrence and limited metastases are conventionally treated with androgen deprivation therapy.NCT01558427·Ghent

RecruitingHyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active SurveillanceThis phase II trial studies the side how well hyperpolarized carbon C 13 pyruvate (HP C-13 pyruvate) magnetic resonance imaging (MRI) works in monitoring patients with prostate…NCT03933670·San Francisco, California

Active not recruitingCognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate CancerThis clinical trial studies cognitive function in men with prostate cancer treated with androgen receptor directed therapies such as abiraterone acetate and enzalutamide.NCT03016741·Los Angeles, California and 4 others

SuspendedLIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate CancerThis is a single center, single arm Phase I study to establish the safety and efficacy of intravenously administered lentivirally transduced LIGHT-PSMA-specific CAR modified…NCT04053062·Shanghai, Shanghai Municipality

TerminatedEffect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic SurgeryControlling pain is fundamental during and after surgical procedures. This study examines pain associated with robotic assisted surgery on prostate cancer or a kidney mass.NCT03824808·Columbia, Missouri

RecruitingClinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical CystectomySubjects will be randomized into 2 groups (stent or no stent) prior to radical cystectomy with ileal conduit urinary diversion (RCIC).NCT07234968·Philadelphia, Pennsylvania and 1 other

Approved for marketingStudy of Abiraterone Acetate in Patients With Advanced Prostate CancerThe purpose of this study is to collect additional safety information on abiraterone acetate administered with prednisone to patients with metastatic castration-resistant prostate…NCT01217697·Birmingham, Alabama and 296 others

Active not recruitingA Study of a Pelvic Floor Muscle Exercise Program Before and After Radical ProstatectomyThe researchers are doing this study to find out if a PFME program to reduce urinary incontinence after radical prostatectomy is feasible for people with prostate cancer.NCT06671782·Basking Ridge, New Jersey and 6 others

RecruitingPersonalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.A randomized phase III trial to study the effect of adding lymph node irradiation in patients with poor prostate-specific antigen (PSA) response during salvage radiotherapy for…NCT04858880·Jönköping and 2 others

RecruitingGU-01: Glycyrrhizin in Prostate CancerThis is a pilot, randomized, window-of-opportunity treatment trial in which participants with previously untreated prostate cancer (PCa) who are candidates for surgery (radical…NCT06378346·Chicago, Illinois

RecruitingUpright MRI for Prostate Cancer ScreeningThis is an investigator initiated study to test the efficacy of an upright MRI (Magnetic Resonance Imaging) for the screening of prostate cancer.NCT03474913·New York, New York

Active not recruitingOnco-primary Care Networking to Support TEAM-based CareThe proposed ONE TEAM Study is an 18-month, cluster randomized controlled trial.NCT04258813·Durham, North Carolina

Active not recruitingIntraprostatic Anesthesia During Transperineal Prostate BiopsyTransperineal prostate biopsy has become the standard method for diagnosing prostate cancer because of its favorable safety profile and low infectious complication rates.NCT07683182·Istanbul, Pendik

RecruitingA Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate CancerThe purpose of this study is to assess the safety, tolerability, pharmacokinetics/pharmacodynamics, preliminary anti-tumor activity, and recommended dose of INR731 as a single…NCT07570979·Boston, Massachusetts and 12 others

CompletedStudy of Sorafenib and Docetaxel in Metastatic Prostate CancerThe purpose of this study is to use Sorafenib plus Docetaxel to evaluate pharmacodynamics (PD) in Patients with prostate cancer.NCT00619996·Pisa, Pisa

WithdrawnS0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsRATIONALE: Vandetanib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT00937417

CompletedA Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.An open-label, multicenter, Phase 1b/2 study to identify the recommended Phase 2 dose and assess the efficacy and safety of BXCL701 administered orally, as monotherapy and in…NCT03910660·San Francisco, California and 11 others

PreviousPage 15 of 377Next